Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.2 |
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.034 | 0.2 |
mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.054 | 0.2 |
mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.2 |
mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.2 |
mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.2 |
mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |